Arnicare Bruise Tablet
Product Images NDC 0220-9083

4 FDA label images from Boiron · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Arnicare Bruise (NDC 0220-9083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Arnicare Bruise 60 Tab Etu.1kls 0625)

Label (Arnicare Bruise 60 Tab Etu.1kls 0625)
Label for Arnicare Bruise Meltaway Tablets containing Arnica Montana 9 HPUS, an oral homeopathic medicine by Boiron. The label highlights bruise relief for discoloration, pain, and swelling, with 60 unflavored meltaway tablets per package. The accompanying Drug Facts panel outlines active and inactive ingredients, uses, warnings, directions, and contact information for Boiron.*
FDA Label Image

Label (Arnicare Bruise 60 Tab Alu.1ku7 Alu.1ku8)

Label (Arnicare Bruise 60 Tab Alu.1ku7 Alu.1ku8)
Drug facts text panel for Arnicare Bruise tablet containing Arnica Montana 9C. Instructions for adults and children 6 years and older include dissolving 2 tablets under the tongue and repeating up to 3 times daily, with guidance for children 2 to under 6 years and advice to ask a doctor for children under 2 years.*
FDA Label Image

Etu.1gyc (Arnicare Bruise Tablets Etu.1gyc 11.2021)

Etu.1gyc (Arnicare Bruise Tablets Etu.1gyc 11.2021)
Drug Facts panel for Arnicare Bruise tablets containing Arnica Montana 9 HPUS 2.5 mg. The panel details active ingredient, purpose, uses for bruising symptoms, warnings, directions for different age groups, inactive ingredients, and contact information for Boiron. It includes Boiron's commitment to product quality and indicates the product is made in France.*
FDA Label Image

Label (Arnicare Bruise Tablets Foil Alu.1gyd)

Label (Arnicare Bruise Tablets Foil Alu.1gyd)
Text panel from Arnicare Bruise 9C tablets by Boiron providing dosing instructions for bruise relief. It directs adults and children 6 years and older to dissolve tablets in the mouth with specific timing, with separate instructions for children aged 2 to 5 years involving dissolving tablets in water, and advises consultation for children under 2 years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.